In turn, this triggers NK-cell activation, as now the signals of the inhibitory receptors are absent, which then activates the NK cells against the tumour cells in interaction with the HLA-independent activating receptors like NCR and NKG2D [19]. Here, KLRK1 is linked to neoplasm.